Our Pipeline

Vaxdigm presents a new production standard for next-gen biomaterials and progresses the manufacturing paradigm for global bio industry


FGF (VXD304)

Material Fibroblast Growth Factor, FGF
Project Seoul R&D
Development progress
Identification of contesting materials Formula research

Overview


FGF is a growth factor which simultaneously encourages both angiogenesis tissue remodeling, being known for tissue-level regeneration. However, FGF is structurally unstable and has a short biological half-life and therefore has limitations in real-situation applications. Vaxdigm progresses for an FGF with maintained biological function yet with improved stability through protein engineering and ChaperNova™-based expression, advancing to a function protein which not only addresses productive efficiency but also structural stability. Through this, we will be able to expand from regenerative treatments and tissue-engineering to functional cosmetics, and we aim to present the substance in combination with a delivery system into various forms such as stick-on patches.


 FGF (VXD304)

Material Fibroblast Growth Factor, FGF
Project Seoul R&D
Development progress
Identification of contesting materials Formula research

Overview


FGF is a growth factor which simultaneously encourages both angiogenesis tissue remodeling, being known for tissue-level regeneration. However, FGF is structurally unstable and has a short biological half-life and therefore has limitations in real-situation applications. Vaxdigm progresses for an FGF with maintained biological function yet with improved stability through protein engineering and ChaperNovaTM-based expression, advancing to a function protein which not only addresses productive efficiency but also structural stability. Through this, we will be able to expand from regenerative treatments and tissue-engineering to functional cosmetics, and we aim to present the substance in combination with a delivery system into various forms such as stick-on patches.


Vaxdigm Co., Ltd.

CEO Sung Jae Kim

TEL 02-6205-2550

EMAIL hydrogold@vaxdigm.com

BUSINESS NUMBER 657-87-02464

ADDRESS 412ho, 201, Songpa-daero, Songpa-gu, Seoul, Republic of Korea

PRIVACY POLICYㅣTERMS AND CONDITIONS

COPYRIGHT © 2026 VAXDIGM. ALL RIGHTS RESERVED.


Vaxdigm Co., Ltd. 

CEO Sung Jae Kim

EMAIL hydrogold@vaxdigm.com ㅣ TEL 02-6205-2550

BUSINESS NUMBER 657-87-02464 ㅣ ADDRESS 412ho, 201, Songpa-daero, Sonpa-gu, Seoul, Republic of Korea

PRIVACY POLICYㅣTERMS AND CONDITIONS

COPYRIGHT © 2026 VAXDIGM. ALL RIGHTS RESERVED.